Related Experiment Videos
Recent advances in ischaemic heart disease
M Cusack1, S Redwood, J Coltart
1Cardiothoracic Unit, St Thomas' Hospital, London SE1 7EH, UK. michael.cusack@kcl.ac.uk
Insights
Developments in understanding coronary artery disease pathogenesis and management are ongoing. This review focuses on medical and interventional treatments, excluding percutaneous interventions, highlighting new stent designs and future therapies.
Area of Science:
- Cardiology
- Vascular Biology
- Medical Interventions
Background:
- Coronary artery disease (CAD) pathogenesis understanding is evolving.
- Significant advancements in medical and interventional management of ischemic heart disease are noted.
- This review specifically excludes percutaneous coronary intervention (PCI) developments.
Purpose of the Study:
- To summarize recent advancements in coronary artery disease management.
- To highlight the impact of novel stent designs and interventional devices.
- To provide an overview of current and future therapeutic strategies for obstructive coronary disease.
Main Methods:
- Literature review focusing on medical and interventional cardiology.
- Analysis of the impact of new stent designs and interventional devices.
- Discussion of emerging therapies like intracoronary radiotherapy and gene therapy.
Main Results:
- New stent designs and interventional devices have significantly impacted obstructive coronary disease treatment.
- Intracoronary radiotherapy shows promise for reducing restenosis after percutaneous transluminal coronary angioplasty (PTCA).
- Gene therapy is being explored to promote angiogenesis in ischemic myocardium.
Conclusions:
- Continuous progress in understanding CAD pathogenesis and treatment is evident.
- Novel interventional devices have improved obstructive coronary disease management.
- Future therapeutic avenues include radiotherapy and gene therapy for CAD.
- Further research into advanced therapies will shape future cardiovascular disease treatment.
Abstract:
There continue to be important developments in the understanding of the pathogenesis of coronary artery disease. Advances have also been made in both the medical and interventional management of patients with ischaemic heart disease. This review has, however, not focused on the wider developments that have occurred in the area of percutaneous intervention. The vast array of new stent designs and other interventional devices have had a considerable impact on the treatment of obstructive coronary disease. In addition it is likely that further developments will be seen in areas such as intracoronary radiotherapy to reduce restenosis after PTCA and in gene therapy to promote angiogenesis in ischaemic myocardium. Both of which will be discussed in a future review of this area.